NYMX
NASDAQNymox Pharmaceutical Corporation
SectorHealth CareIndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
Latest news
25 items- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- PRNymox UpdateIRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the "Company") is providing additional information concerning recent changes in the Company's board of directors (the "Board") and management, as well as additional information regarding the Company's conclusion that a potential transaction was not in the best interests of the Nymox and its shareholders. Nymox recently terminated the employment of Mr. Randall Lanham, the Company's former in-house legal counsel, and Mr. Christopher Riley, the Company's former chief financial officer. Mr. Lanham and Mr. Cutler were removed from the Board. Mr. Lanham (legal counsel) and Mr. Riley (CFO)
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- PRNymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxIRVINE, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the "Company") is pleased to announce the appointment of Patrick Doody as Nymox Vice President, General Counsel, and Member of Nymox Board of Directors. Mr. Doody joins Nymox from Pillsbury Winthrop Shaw Pittman LLP, where he was a partner in the Intellectual Property Group, and currently is Senior Counsel. Mr. Doody is a well-respected patent attorney with significant knowledge and experience in post-grant proceedings, patent infringement litigation, patent prosecution, licensing, opinions, and counseling. Mr. Doody has represented Nymox and its predecessor company in intellectual pr
- PRNYMOX UpdateIRVINE, Calif., July 07, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the "Company") is providing information to address requests it has received for further information concerning recent changes to the Company's Board of Directors ("Board") and the Company's management. Two former employees (the "Former Employees") of the Company proposed to the Company a potential transaction (the "Proposed Transaction"). The Company, its employees, and the Former Employees are bound by an obligation not to disclose any details of the Proposed Transaction. The terms of the Proposed Transaction were thoroughly reviewed and it was determined that it was not in the bes
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Caribou Biosciences (NASDAQ:CRBU) stock rose 50.7% to $6.15 during Thursday's regular session. The current volume of 75.4 million shares is 9750.6% of Caribou Biosciences's average full-day volume over the last 100 days (last updated at 13:37 EST). The company's market cap stands at $377.3 million. Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 26.08% to $0.43. Aethlon Medical's stock is trading at a volume of 6.0 million shares as of 13:37 EST. This is 647.1% of its average full-day volume over the last 100 days. The company's market cap stands at $10.6 million. Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 16.93% to $2.17. As of 13:37 EST, this security is tradi
- NEWSNymox Pharmaceutical shares are trading lower after the company received a Nasdaq delisting notice.
- NEWSWhy Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionGainers Caribou Biosciences, Inc. (NASDAQ:CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer. Mullen Automotive, Inc. (NASDAQ:MULN) shares climbed 53.1% to $ 0.2616 fter the company on Wednesday announced the retention of a law group to investigate possible naked short selling. The company also announced a buyback on Thursday. T2 Biosystems, Inc. (NASDAQ:TTOO) gained 27.5% to $0.0944. T2 Biosystems announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into its common stock and Series B convertible preferred stock. Borqs Technologies, Inc. (NASDAQ:BRQS) jumped 23.5% to $0.19
- NEWS12 Health Care Stocks Moving In Thursday's Pre-Market SessionGainers Incannex Healthcare (NASDAQ:IXHL) stock rose 32.2% to $2.46 during Thursday's pre-market session. The market value of their outstanding shares is at $156.1 million. Caribou Biosciences (NASDAQ:CRBU) shares rose 31.37% to $5.36. The market value of their outstanding shares is at $328.9 million. Biodesix (NASDAQ:BDSX) stock rose 14.51% to $1.42. The market value of their outstanding shares is at $111.5 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 12.02% to $1.49. The company's market cap stands at $13.4 million. Aethlon Medical (NASDAQ:AEMD) stock moved upwards by 11.76% to $0.38. The company's market cap stands at $9.4 million. Intelligent Bio Solutions (NASDAQ:INBS)
- NEWSWhy VBI Vaccines Are Trading Lower By Over 23%; Here Are 20 Stocks Moving PremarketGainers Akumin Inc. (NASDAQ:AKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company. Mullen Automotive, Inc. (NASDAQ:MULN) shares gained 52.8% to $0.2612 in pre-market trading. Mullen Automotive shares jumped 69% on Wednesday after the company announced the retention of a law group to investigate possible naked short selling. Micromobility.com Inc. (NASDAQ:MCOM) shares rose 19.8% to $0.1354 in pre-market trading. micromobility.com recently announced a strategic realignment to strengthen its financial position and drive profitability. Caravelle International Group (NASDAQ:CACO) rose 19.6% to $
- PRNymox Delisting from NASDAQIRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) (the "Company") today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq, and hence the Company's shares will be suspended from trading on NASDAQ at the open of business on July 7, 2023. Nymox shares will be moved to the OTC market. The mechanics of trading the stock remain the same, as do the Company's business fundamentals. Nymox is in the process of submitting applications for the approval to market the Company's first in class drug NYMOZARFEX to treat the symptoms of benign pro
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Impel Pharmaceuticals (NASDAQ:IMPL) shares rose 34.7% to $1.68 during Wednesday's pre-market session. The company's market cap stands at $39.8 million. C4 Therapeutics (NASDAQ:CCCC) shares rose 19.08% to $3.37. The market value of their outstanding shares is at $165.3 million. RVL Pharmaceuticals (NASDAQ:RVLP) stock rose 15.34% to $0.64. The market value of their outstanding shares is at $63.0 million. Plus Therapeutics (NASDAQ:PSTV) stock moved upwards by 13.08% to $2.31. The company's market cap stands at $5.7 million. GRI Bio (NASDAQ:GRI) shares increased by 11.26% to $4.94. The company's market cap stands at $14.4 million. MAIA Biotechnology (AMEX:MAIA) shares increased by
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Nymox Pharmaceutical (NASDAQ:NYMX) stock moved upwards by 31.7% to $0.25 during Tuesday's regular session. Trading volume for Nymox Pharmaceutical's stock is 3.3 million as of 13:37 EST. This is 5697.9% of its average full-day volume over the last 100 days. The company's market cap stands at $22.8 million. Ensysce Biosciences (NASDAQ:ENSC) shares rose 31.11% to $2.36. Ensysce Biosciences's stock is trading at a volume of 11.1 million shares as of 13:37 EST. This is 1720.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.8 million. IMAC Hldgs (NASDAQ:BACK) stock moved upwards by 27.63% to $0.14. As of 13:37 EST, IMAC Hldg
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers SQZ Biotechnologies (NYSE:SQZ) shares increased by 68.1% to $0.45 during Monday's regular session. The current volume of 30.0 million shares is 44863.5% of SQZ Biotechnologies's average full-day volume over the last 100 days (last updated at 13:37 EST). The market value of their outstanding shares is at $13.3 million. Nymox Pharmaceutical (NASDAQ:NYMX) shares rose 31.68% to $0.25. Nymox Pharmaceutical's stock is trading at a volume of 3.3 million shares as of 13:37 EST. This is 5697.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.8 million. Ensysce Biosciences (NASDAQ:ENSC) shares increased by 31.11% to $2.36. Tradin
- SECSEC Form 6-K filed by Nymox Pharmaceutical Corporation6-K - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
- SECSEC Form 6-K/A filed by Nymox Pharmaceutical Corporation (Amendment)6-K/A - NYMOX PHARMACEUTICAL CORP (0001018735) (Filer)
NYMX FAQ
5 questionsWhat does Nymox Pharmaceutical Corporation do?
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect...Where does NYMX stock trade?
Nymox Pharmaceutical Corporation (NYMX) is listed on NASDAQ.What sector and industry is NYMX in?
Nymox Pharmaceutical Corporation operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.What companies are similar to NYMX?
Notable peers in the same industry include IDXX (IDEXX Laboratories Inc.), LNTH (Lantheus Holdings Inc.), OCDX (Ortho Clinical Diagnostics Holdings plc), ORKA (Oruka Therapeutics Inc.), NNNN (Anbio Biotechnology). Compare NYMX side-by-side with any of them on Quantisnow.How can I track NYMX on Quantisnow?
Quantisnow aggregates Nymox Pharmaceutical Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NYMX to receive live email and push alerts on every new disclosure.